Andrea Charles | 12/22/2010
Toxicology formulation is an essential component of drug development. Dr. Chong-Hui Gu, Associate Director at Vertex Pharmaceuticals, joins Andrea Charles from Pharma IQ, to discusss how novel formulation technologies can solve the exposure limit of poorly soluble compounds and the how the industry is seeking to overcome the challenges that arise in toxicology formulation development.
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More